跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
XGEVA denosumab (rch) 120 mg/mL solution for injection pre-filled syringe with automatic needle guard - TGA Drug Approval Details
Approvals
/
TGA
/
XGEVA denosumab (rch) 120 mg/mL solution for injection pre-filled syringe with automatic needle guard
Approved
STANDARD
XGEVA denosumab (rch) 120 mg/mL solution for injection pre-filled syringe with automatic needle guard
Amgen Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
88014b1f6d0e1bbe
Company
Amgen Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
88014b1f6d0e1bbe
Product Name
XGEVA denosumab (rch) 120 mg/mL solution for injection pre-filled syringe with automatic needle guard
Artg Id
438913
Artg Name
XGEVA denosumab (rch) 120 mg/mL solution for injection pre-filled syringe with automatic needle guard
Sponsor
Amgen Australia Pty Ltd
Company Detail Path
/organization/amgen-australia-pty-ltd
Artg Date
2024-12-06
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Product Information
https://medical-cdn.nocode.com/drug_tga/ac9b020ce6416bb7b5f3af385614eb10.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
88014b1f6d0e1bbe
Type
Standard
Back to TGA Approvals